Acorda Therapeutics
ACOR
#11271
Rank
S$1.05 M
Marketcap
S$0.85
Share price
0.00%
Change (1 day)
-95.68%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -S$0.36 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are S$0.11 Billion. In 2023 the company made an earning of -S$0.35 Billion a decrease over its 2022 earnings that were of -S$6.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.36 Billion5.59%
2023 -S$0.35 Billion4848.63%
2022 -S$6.89 Million-93.25%
2021 -S$0.11 Billion2.52%
2020 -S$99.42 Million-69.45%
2019 -S$0.33 Billion-700.62%
2018 S$54.18 M-118.02%
2017 -S$0.31 Billion805.99%
2016 -S$33.2 Million-173.88%
2015 S$44.92 M-6.58%
2014 S$48.09 M20.19%
2013 S$40.01 M18.7%
2012 S$33.71 M-26.54%
2011 S$45.89 M
2009 -S$0.11 Billion10.65%
2008 -S$94.71 Million86.17%
2007 -S$50.87 Million68.1%
2006 -S$30.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-S$0.17 Billion-51.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S$39.56 M-111.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-S$98.62 Million-71.86%๐Ÿ‡ฉ๐Ÿ‡ช Germany
BioMarin Pharmaceutical
BMRN
S$56.3 M-116.07%๐Ÿ‡บ๐Ÿ‡ธ USA